Yuya Takahashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yuya Takahashi has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Chigen Tsukamoto
Faculty of Agriculture, Iwate University, 3-18-8 Ueda, Morioka 020-8550, Japan
2 shared publications - Hae Reon Son
Faculty of Agriculture Iwate University Morioka Iwate 020‐8550 Japan
2 shared publications - Hiroki Fujita
Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine, Akita 010-8543, Japan
2 shared publications - Hironori Waki
Department of Metabolism and Endocrinology Akita University Graduate School of Medicine Akita Japan
2 shared publications Tatsunori Shimizu
Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine, Akita, Japan; Advanced Research Center for Geriatric Medicine, Akita University Graduate School of Medicine, Akita, Japan
2 shared publications- Aiko Nara
Division of Diabetes and Endocrinology, Nakadori General Hospital, Akita, Japan
1 shared publication
Latest Publications
- 8 October 2026
- Published by American Diabetes Association in Diabetes
Olive Oil Before Oral Glucose Delays Gastric Emptying and Lowers Glycemia Through Partially Redundant Glucagon and GLP-1 Signaling in Mice
Consumption of fat before carbohydrate (preload) attenuates postprandial glucose excursions, although the underlying mechanisms remain unclear. We investigated whether an olive oil preload (OG) reduces glycemia by engaging endocrine and neural regulation of gastric emptying. Wild-type C57BL/6J mice received OG or olive oil after (GO) an oral glucose load, with a water preload (WG) as control. Glucose, insulin, glucagon, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and gastric emptying were assessed. Studies were also performed in streptozotocin-induced diabetic mice, NSY diabetic mice, Gcg-deficient and Glp1r-deficient mice, mice receiving glucagon and/or GLP-1 receptor blockade, and mice subjected to bilateral subdiaphragmatic vagus nerve ligation (VNL). Compared with WG and GO, OG reduced the early glucose excursion and slowed gastric emptying, accompanied by increased glucagon, GIP, and GLP-1 secretion. Similar effects were evident in diabetic mice. The response was absent in Gcg-deficient mice but largely preserved in Glp1r-deficient mice and following blockade of either receptor alone. Combined receptor blockade attenuated glucose lowering and eliminated detectable gastric slowing, supporting partially redundant signaling. VNL attenuated these effects, despite preserved or enhanced hormone secretion, supporting a contribution of vagal signaling. These findings identify nutrient timing as an integrated endocrine-neural regulator of postchallenge blood glucose homeostasis. Article Highlights: We undertook this study to define how fat consumed before oral glucose attenuates postchallenge glycemia. We asked whether olive oil reduces glycemia by slowing gastric emptying and investigated contributing endocrine and neural pathways. Olive oil increased glucagon, glucose-dependent insulinotropic polypeptide, and glucagon-like peptide-1; slowed gastric emptying; and reduced early glycemia in mice. Glucagon and glucagon-like peptide-1 signaling acted redundantly, with vagal involvement. Nutrient timing integrates endocrine-neural regulation of gastric emptying and glycemia, supporting evaluation of meal sequencing in humans.
- 8 October 2026
- Published by American Diabetes Association in Diabetes
Olive Oil Before Oral Glucose Delays Gastric Emptying and Lowers Glycemia Through Partially Redundant Glucagon and GLP-1 Signaling in Mice
Consumption of fat before carbohydrate (preload) attenuates postprandial glucose excursions, although the underlying mechanisms remain unclear. We investigated whether an olive oil preload (OG) reduces glycemia by engaging endocrine and neural regulation of gastric emptying. Wild-type C57BL/6J mice received OG or olive oil after (GO) an oral glucose load, with a water preload (WG) as control. Glucose, insulin, glucagon, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and gastric emptying were assessed. Studies were also performed in streptozotocin-induced diabetic mice, NSY diabetic mice, Gcg-deficient and Glp1r-deficient mice, mice receiving glucagon and/or GLP-1 receptor blockade, and mice subjected to bilateral subdiaphragmatic vagus nerve ligation (VNL). Compared with WG and GO, OG reduced the early glucose excursion and slowed gastric emptying, accompanied by increased glucagon, GIP, and GLP-1 secretion. Similar effects were evident in diabetic mice. The response was absent in Gcg-deficient mice but largely preserved in Glp1r-deficient mice and following blockade of either receptor alone. Combined receptor blockade attenuated glucose lowering and eliminated detectable gastric slowing, supporting partially redundant signaling. VNL attenuated these effects, despite preserved or enhanced hormone secretion, supporting a contribution of vagal signaling. These findings identify nutrient timing as an integrated endocrine-neural regulator of postchallenge blood glucose homeostasis. Article Highlights: We undertook this study to define how fat consumed before oral glucose attenuates postchallenge glycemia. We asked whether olive oil reduces glycemia by slowing gastric emptying and investigated contributing endocrine and neural pathways. Olive oil increased glucagon, glucose-dependent insulinotropic polypeptide, and glucagon-like peptide-1; slowed gastric emptying; and reduced early glycemia in mice. Glucagon and glucagon-like peptide-1 signaling acted redundantly, with vagal involvement. Nutrient timing integrates endocrine-neural regulation of gastric emptying and glycemia, supporting evaluation of meal sequencing in humans.
- Open Access
- 22 September 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 229, 112913
Impact of Tirzepatide on diet-related quality of life and treatment satisfaction in people with type 2 diabetes mellitus: a retrospective cross-sectional study
- 22 September 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 229, 112913
Open AccessImpact of Tirzepatide on diet-related quality of life and treatment satisfaction in people with type 2 diabetes mellitus: a retrospective cross-sectional study
- Open Access
- 24 February 2022
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 13 (7) , 1132-1133
Pick the best of both glucose and lipid metabolism
Isthmin‐1 is an adipokine that has a potent glucose‐lowering effect by stimulating a common intracellular signaling pathway with insulin through a distinct receptor and has an inhibitory effect on lipogenesis in the liver, whereas insulin has the opposite effect. Isthmin‐1 is expected to have clinical benefits in the treatment of diabetes.
- 24 February 2022
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 13 (7) , 1132-1133
Open AccessPick the best of both glucose and lipid metabolism
Isthmin‐1 is an adipokine that has a potent glucose‐lowering effect by stimulating a common intracellular signaling pathway with insulin through a distinct receptor and has an inhibitory effect on lipogenesis in the liver, whereas insulin has the opposite effect. Isthmin‐1 is expected to have clinical benefits in the treatment of diabetes.
- 12 February 2019
- Published by Oxford University Press (OUP) in Plant and Cell Physiology
- Vol. 60 (5) , 1082-1097
High-Throughput Screening and Characterization of a High-Density Soybean Mutant Library Elucidate the Biosynthesis Pathway of Triterpenoid Saponins
Triterpenes (C30) constitute one of the diverse class of natural products with potential applications in food, cosmetic and pharmaceutical industries. Soyasaponins are oleanane-type triterpenoids widespread among legumes and particularly abundant in soybean seeds. They have associated with various pharmacological implications and undesirable taste properties of soybean-based food products. Uncovering the biosynthetic genes of soyasaponins will provide new opportunities to control the pathway for human benefits. However, the pathway of soyasaponin biosynthesis has not been fully elucidated in part because of a paucity of natural mutants. Here, we applied a structured high-density soybean mutant library for the forward genetic screening of triterpenoid biosynthesis. The seed soyasaponin polymorphism in the mutant library was evaluated using a high-throughput thin-layer chromatography and liquid chromatography tandem mass spectrometry analysis. This screening identified 35 mutants (3.85% of 909 mutant lines) with seven unusual soyasaponin phenotypes (Categories 1-7), which was greater than the number of natural mutants reported previously (22 mutants, 0.18% of ∼12,428 accessions). Nine unique intermediates of soyasaponin biosynthesis were identified and their chemical structures were estimated based on their MS/MS fragment patterns. Based on published information, 19 mutants could be associated with loss of function of four individual soyasaponin biosynthesis genes identified through expressed sequence tag mining or positional cloning, whereas the remaining 16 mutants were novel and may facilitate discovery of the unknown biosynthetic genes of soyasaponins. Our approach and library may help to identify new phenotype materials and causative genes associated with specialized metabolite production and other traits.
- 12 February 2019
- Published by Oxford University Press (OUP) in Plant and Cell Physiology
- Vol. 60 (5) , 1082-1097
High-Throughput Screening and Characterization of a High-Density Soybean Mutant Library Elucidate the Biosynthesis Pathway of Triterpenoid Saponins
Triterpenes (C30) constitute one of the diverse class of natural products with potential applications in food, cosmetic and pharmaceutical industries. Soyasaponins are oleanane-type triterpenoids widespread among legumes and particularly abundant in soybean seeds. They have associated with various pharmacological implications and undesirable taste properties of soybean-based food products. Uncovering the biosynthetic genes of soyasaponins will provide new opportunities to control the pathway for human benefits. However, the pathway of soyasaponin biosynthesis has not been fully elucidated in part because of a paucity of natural mutants. Here, we applied a structured high-density soybean mutant library for the forward genetic screening of triterpenoid biosynthesis. The seed soyasaponin polymorphism in the mutant library was evaluated using a high-throughput thin-layer chromatography and liquid chromatography tandem mass spectrometry analysis. This screening identified 35 mutants (3.85% of 909 mutant lines) with seven unusual soyasaponin phenotypes (Categories 1-7), which was greater than the number of natural mutants reported previously (22 mutants, 0.18% of ∼12,428 accessions). Nine unique intermediates of soyasaponin biosynthesis were identified and their chemical structures were estimated based on their MS/MS fragment patterns. Based on published information, 19 mutants could be associated with loss of function of four individual soyasaponin biosynthesis genes identified through expressed sequence tag mining or positional cloning, whereas the remaining 16 mutants were novel and may facilitate discovery of the unknown biosynthetic genes of soyasaponins. Our approach and library may help to identify new phenotype materials and causative genes associated with specialized metabolite production and other traits.
- 1 July 2018
- Published by Elsevier in Journal of Cardiology
- Vol. 72 (1) , 19-25
Feasibility of total intravenous anesthesia by cardiologists with the support of anesthesiologists during catheter ablation of atrial fibrillation
- 1 July 2018
- Published by Elsevier in Journal of Cardiology
- Vol. 72 (1) , 19-25
Feasibility of total intravenous anesthesia by cardiologists with the support of anesthesiologists during catheter ablation of atrial fibrillation